Virtus Fund Advisers’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-277
Closed -$20K 626
2015
Q4
$20K Sell
277
-99
-26% -$7.06K ﹤0.01% 518
2015
Q3
$28K Hold
376
﹤0.01% 474
2015
Q2
$24K Sell
376
-1,616
-81% -$112K ﹤0.01% 507
2015
Q1
$154K Sell
1,992
-192
-9% -$14.9K ﹤0.01% 428
2014
Q4
$162K Sell
2,184
-76
-3% -$5.33K ﹤0.01% 463
2014
Q3
$133K Sell
2,260
-10,826
-83% -$684K ﹤0.01% 510
2014
Q2
$874K Buy
+13,086
New +$832K 0.01% 472

Other funds holding IDXX

Virtus Fund Advisers's IDXX Position: Q1 2016 in Review

Virtus Fund Advisers sold out of Idexx Laboratories (IDXX) in Q1 2016, closing a stake of 277 shares — an estimated $20K sold.

Virtus Fund Advisers first reported a position in IDXX in Q2 2014 and held it in 7 quarters. The position peaked at $874K in Q2 2014. 376 funds tracked by Wall St. Rank hold IDXX as of Q1 2016.

  • Virtus Fund Advisers reported no remaining Idexx Laboratories position as of Q1 2016 after selling out during the quarter.
  • Virtus Fund Advisers sold 277 Idexx Laboratories shares in Q1 2016, an estimated $20K.
  • Virtus Fund Advisers first reported a position in Idexx Laboratories in Q2 2014 and held it in 7 quarters.
  • Virtus Fund Advisers's Idexx Laboratories position peaked at $874K in Q2 2014.
  • 376 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2016.

Based on Virtus Fund Advisers's 13F filing for Q1 2016, filed 11 May 2016.